[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Procept Biorobotics Corp (PRCT)

Procept Biorobotics Corp (PRCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,217,072
  • Shares Outstanding, K 57,274
  • Annual Sales, $ 308,050 K
  • Annual Income, $ -95,570 K
  • EBIT $ -114 M
  • EBITDA $ -108 M
  • 60-Month Beta 0.89
  • Price/Sales 4.03
  • Price/Cash Flow N/A
  • Price/Book 3.63

Options Overview Details

View History
  • Implied Volatility 58.16% (-6.36%)
  • Historical Volatility 55.34%
  • IV Percentile 15%
  • IV Rank 16.37%
  • IV High 112.02% on 07/24/26
  • IV Low 47.62% on 08/28/25
  • Expected Move (DTE 24) 0.67 (3.11%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 201
  • Volume Avg (30-Day) 469
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 8,452
  • Open Int (30-Day) 10,902
  • Expected Range 20.93 to 22.27

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.39
  • Number of Estimates 5
  • High Estimate $-0.35
  • Low Estimate $-0.42
  • Prior Year $-0.38
  • Growth Rate Est. (year over year) -2.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.86 +28.11%
on 07/27/26
22.93 -5.80%
on 08/11/26
+4.91 (+29.42%)
since 07/24/26
3-Month
16.67 +29.61%
on 07/24/26
29.74 -27.37%
on 06/09/26
-7.40 (-25.52%)
since 05/22/26
52-Week
16.67 +29.61%
on 07/24/26
42.43 -49.09%
on 09/02/25
-17.71 (-45.05%)
since 08/25/25

Most Recent Stories

More News
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Contact the Firm Before the Deadline on September 22, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BAC : 62.43 (+0.16%)
PRCT : 21.60 (+1.65%)
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm Before Lead Plaintiff Deadline on September 22, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BAC : 62.43 (+0.16%)
PRCT : 21.60 (+1.65%)
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BAC : 62.43 (+0.16%)
PRCT : 21.60 (+1.65%)
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 24, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors...

PRCT : 21.60 (+1.65%)
PRCT INVESTOR ALERT: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN FRANCISCO , Aug. 24, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed...

PRCT : 21.60 (+1.65%)
PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT

LOS ANGELES , Aug. 24, 2026 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or "the Company") (NASDAQ: PRCT...

PRCT : 21.60 (+1.65%)
PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT

NEW ORLEANS , Aug. 21, 2026 /PRNewswire/ -- ClaimsFiler , a FREE shareholder information service, reminds investors that they have until  September 22, 2026  to file lead plaintiff applications...

PRCT : 21.60 (+1.65%)
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 21, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors...

PRCT : 21.60 (+1.65%)
Kaplan Fox Alerts Investors to an Upcoming Deadline of September 22, 2026 in the PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Securities Class Action

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BAC : 62.43 (+0.16%)
PRCT : 21.60 (+1.65%)
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

NEW YORK , Aug. 21, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28,...

PRCT : 21.60 (+1.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics, formerly known as PROCEPT THERAP, is based in San Jose, California.

See More

Key Turning Points

3rd Resistance Point 22.46
2nd Resistance Point 22.07
1st Resistance Point 21.83
Last Price 21.60
1st Support Level 21.20
2nd Support Level 20.81
3rd Support Level 20.57

See More

52-Week High 42.43
Fibonacci 61.8% 32.59
Fibonacci 50% 29.55
Fibonacci 38.2% 26.51
Last Price 21.60
52-Week Low 16.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.